[1] HIPPIUS H, NEUNDÖRFER G. The discovery of Alzheimer’s disease[J]. Dialogues in Clinical Neuroscience, 2003, 5(1): 101–108.
[2] MAURER K, VOLK S, GERBALDO H. Auguste D and Alzheimer’s disease[J]. THE LANCET, 1997, 349.
[3] ALZHEIMER A. Uber einen eigenartigen schweren Er Krankungsprozeb der Hirnrinde[J]. Neurologisches Centralblatt, 1906, 23: 1129–1136.
[4] SCHÖLL M, LOCKHART S N, SCHONHAUT D R, et al. PET Imaging of Tau Deposition in the Aging Human Brain[J]. Neuron, 2016, 89(5): 971–982.
[5] GRAEBER M B, KÖSEL S, GRASBON-FRODL E, et al. Histopathology and APOE genotype of the first Alzheimer disease patient, Auguste D[J]. Neurogenetics, 1998, 1(3): 223–228.
[6] 2023 Alzheimer’s disease facts and figures[J]. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 2023, 19(4): 1598–1695.
[7] Dementia[EB/OL]. https://www.who.int/news-room/fact-sheets/detail/dementia.
[8] QUERFURTH H W, LAFERLA F M. Alzheimer’s disease[J]. The New England Journal of Medicine, 2010, 362(4): 329–344.
[9] GOEDERT M, SPILLANTINI M G. A century of Alzheimer’s disease[J]. Science (New York, N.Y.), 2006, 314(5800): 777–781.
[10] SELKOE D J, HARDY J. The amyloid hypothesis of Alzheimer’s disease at 25 years[J]. EMBO molecular medicine, 2016, 8(6): 595–608.
[11] BALLATORE C, LEE V M-Y, TROJANOWSKI J Q. Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders[J]. Nature Reviews. Neuroscience, 2007, 8(9): 663–672.
[12] 田金洲, 解恒革, 王鲁宁, 等. 中国阿尔茨海默病痴呆诊疗指南(2020年版)[J]. 中华老年医学杂志, 2021, 40(3): 15.
[13] BRIGGS R, KENNELLY S P, O’NEILL D. Drug treatments in Alzheimer’s disease[J]. Clinical Medicine (London, England), 2016, 16(3): 247–253.
[14] PASSERI E, ELKHOURY K, MORSINK M, et al. Alzheimer’s Disease: Treatment Strategies and Their Limitations[J]. International Journal of Molecular Sciences, 2022, 23(22): 13954.
[15] BLENNOW K, HAMPEL H. CSF markers for incipient Alzheimer’s disease[J]. The Lancet Neurology, 2003, 2(10): 605–613.
[16] JANELIDZE S, TEUNISSEN C E, ZETTERBERG H, et al. Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease[J]. JAMA neurology, 2021, 78(11): 1375–1382.
[17] PALMQVIST S, TIDEMAN P, CULLEN N, et al. Prediction of future Alzheimer’s disease dementia using plasma phospho-tau combined with other accessible measures[J]. Nature Medicine, 2021, 27(6): 1034–1042.
[18] JIANG Y, UHM H, IP F C, et al. A blood-based multi-pathway biomarker assay for early detection and staging of Alzheimer’s disease across ethnic groups[J]. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 2024.
[19] LE GUEN Y, BELLOY M E, GRENIER-BOLEY B, et al. Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease[J]. JAMA neurology, 2022, 79(7): 652–663.
[20] BELLENGUEZ C, KÜÇÜKALI F, JANSEN I E, et al. New insights into the genetic etiology of Alzheimer’s disease and related dementias[J]. Nature Genetics, 2022, 54(4): 412–436.
[21] WEINER M W, VEITCH D P, AISEN P S, et al. The Alzheimer’s Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement[J]. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 2017, 13(5): 561–571.
[22] SKLAVENITIS-PISTOFIDIS R, GETZ G, GHOBRIAL I. Single-cell RNA sequencing: one step closer to the clinic[J]. Nature Medicine, 2021, 27(3): 375–376.
[23] GRIFFITHS J A, SCIALDONE A, MARIONI J C. Using single-cell genomics to understand developmental processes and cell fate decisions[J]. Molecular Systems Biology, 2018, 14(4): e8046.
[24] BRIGGS J A, WEINREB C, WAGNER D E, et al. The dynamics of gene expression in vertebrate embryogenesis at single-cell resolution[J]. Science (New York, N.Y.), 2018, 360(6392): eaar5780.
[25] JERBY-ARNON L, SHAH P, CUOCO M S, et al. A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade[J]. Cell, 2018, 175(4): 984-997.e24.
[26] KUPPE C, IBRAHIM M M, KRANZ J, et al. Decoding myofibroblast origins in human kidney fibrosis[J]. Nature, 2021, 589(7841): 281–286.
[27] BOSSEL BEN-MOSHE N, HEN-AVIVI S, LEVITIN N, et al. Predicting bacterial infection outcomes using single cell RNA-sequencing analysis of human immune cells[J]. Nature Communications, 2019, 10(1): 3266.
[28] SHAPIRO E, BIEZUNER T, LINNARSSON S. Single-cell sequencing-based technologies will revolutionize whole-organism science[J]. Nature Reviews. Genetics, 2013, 14(9): 618–630.
[29] KOLODZIEJCZYK A A, KIM J K, SVENSSON V, et al. The technology and biology of single-cell RNA sequencing[J]. Molecular Cell, 2015, 58(4): 610–620.
[30] NAWY T. Single-cell sequencing[J]. Nature Methods, 2014, 11(1): 18.
[31] ZHANG X, LI T, LIU F, et al. Comparative Analysis of Droplet-Based Ultra-High-Throughput Single-Cell RNA-Seq Systems[J]. Molecular Cell, 2019, 73(1): 130-142.e5.
[32] WANG X, HE Y, ZHANG Q, et al. Direct Comparative Analyses of 10X Genomics Chromium and Smart-seq2[J]. Genomics, Proteomics & Bioinformatics, 2021, 19(2): 253–266.
[33] WU F, FAN J, HE Y, et al. Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer[J]. Nature Communications, 2021, 12(1): 2540.
[34] XU K, WANG R, XIE H, et al. Single-cell RNA sequencing reveals cell heterogeneity and transcriptome profile of breast cancer lymph node metastasis[J]. Oncogenesis, 2021, 10(10): 66.
[35] HAQUE A, ENGEL J, TEICHMANN S A, et al. A practical guide to single-cell RNA-sequencing for biomedical research and clinical applications[J]. Genome Medicine, 2017, 9(1): 75.
[36] LUQUEZ T, GAUR P, KOSATER I M, et al. Cell type-specific changes identified by single-cell transcriptomics in Alzheimer’s disease[J]. Genome Medicine, 2022, 14(1): 136.
[37] ZHUANG F, QI Z, DUAN K, et al. A Comprehensive Survey on Transfer Learning[J]. Proceedings of the IEEE, 2021, 109(1): 43–76.
[38] WANG J, HORLACHER M, CHENG L, et al. DeepLocRNA: an interpretable deep learning model for predicting RNA subcellular localization with domain-specific transfer-learning[J]. Bioinformatics (Oxford, England), 2024, 40(2): btae065.
[39] LIN Y, WU T-Y, WAN S, et al. scJoint integrates atlas-scale single-cell RNA-seq and ATAC-seq data with transfer learning[J]. Nature Biotechnology, Nature Publishing Group, 2022, 40(5): 703–710.
[40] WANG J, AGARWAL D, HUANG M, et al. Data denoising with transfer learning in single-cell transcriptomics[J]. Nature Methods, Nature Publishing Group, 2019, 16(9): 875–878.
[41] GAO Y, CUI Y. Deep transfer learning for reducing health care disparities arising from biomedical data inequality[J]. Nature Communications, Nature Publishing Group, 2020, 11(1): 5131.
[42] SONG Y, ZHU S, ZHANG N, et al. Blood Circulating miRNA Pairs as a Robust Signature for Early Detection of Esophageal Cancer[J]. Frontiers in Oncology, 2021, 11: 723779.
[43] WOZNIAK J M, MILLS R H, OLSON J, et al. Mortality Risk Profiling of Staphylococcus aureus Bacteremia by Multi-omic Serum Analysis Reveals Early Predictive and Pathogenic Signatures[J]. Cell, 2020, 182(5): 1311-1327.e14.
[44] CHENG L, LO L-Y, TANG N L S, et al. CrossNorm: a novel normalization strategy for microarray data in cancers[J]. Scientific Reports, 2016, 6: 18898.
[45] LAZAR C, MEGANCK S, TAMINAU J, et al. Batch effect removal methods for microarray gene expression data integration: a survey[J]. Brief Bioinform, 2013, 14(4): 469–90.
[46] MCHUGH L, SELDON T A, BRANDON R A, et al. A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent Cohorts[J]. PLoS Med, 2015, 12(12): e1001916.
[47] SCICLUNA B P, WIEWEL M A, VAN VUGHT L A, et al. Molecular Biomarker to Assist in Diagnosing Abdominal Sepsis upon ICU Admission[J]. Am J Respir Crit Care Med, 2018, 197(8): 1070–1073.
[48] A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium[J]. Nat Biotechnol, 2014, 32(9): 903–14.
[49] LEEK J T, SCHARPF R B, BRAVO H C, et al. Tackling the widespread and critical impact of batch effects in high-throughput data[J]. Nat Rev Genet, 2010, 11(10): 733–9.
[50] WU Q, ZHENG X, LEUNG K-S, et al. meGPS: a multi-omics signature for hepatocellular carcinoma detection integrating methylome and transcriptome data[J]. Bioinformatics, 2022, 38(14): 3513–3522.
[51] ZHENG X, LEUNG K-S, WONG M-H, et al. Long non-coding RNA pairs to assist in diagnosing sepsis[J]. BMC Genomics, 2021, 22(1): 275.
[52] LI Q, ZHENG X, XIE J, et al. bvnGPS: a generalizable diagnostic model for acute bacterial and viral infection using integrative host transcriptomics and pretrained neural networks[J]. Bioinformatics, 2023: btad109.
[53] WANG R, ZHENG X, WANG J, et al. Improving bulk RNA-seq classification by transferring gene signature from single cells in acute myeloid leukemia[J]. Briefings in Bioinformatics, 2022, 23(2): bbac002.
[54] BARRETT T, WILHITE S E, LEDOUX P, et al. NCBI GEO: archive for functional genomics data sets—update[J]. Nucleic Acids Research, 2013, 41(Database issue): D991-995.
[55] OTERO-GARCIA M, MAHAJANI S U, WAKHLOO D, et al. Molecular signatures underlying neurofibrillary tangle susceptibility in Alzheimer’s disease[J]. Neuron, Elsevier, 2022, 0(0).
[56] WANG X, TIAN Y, LI C, et al. Exploring the key ferroptosis-related gene in the peripheral blood of patients with Alzheimer’s disease and its clinical significance[J]. Frontiers in Aging Neuroscience, 2022, 14: 970796.
[57] LIANG W S, DUNCKLEY T, BEACH T G, et al. Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain[J]. Physiological Genomics, 2007, 28(3): 311–322.
[58] LIANG W S, DUNCKLEY T, BEACH T G, et al. Altered neuronal gene expression in brain regions differentially affected by Alzheimer’s disease: a reference data set[J]. Physiological Genomics, 2008, 33(2): 240–256.
[59] LIANG W S, REIMAN E M, VALLA J, et al. Alzheimer’s disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons[J]. Proceedings of the National Academy of Sciences of the United States of America, 2008, 105(11): 4441–4446.
[60] READHEAD B, HAURE-MIRANDE J-V, FUNK C C, et al. Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus[J]. Neuron, 2018, 99(1): 64-82.e7.
[61] NARAYANAN M, HUYNH J L, WANG K, et al. Common dysregulation network in the human prefrontal cortex underlies two neurodegenerative diseases[J]. Molecular Systems Biology, 2014, 10: 743.
[62] NATIVIO R, LAN Y, DONAHUE G, et al. An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer’s disease[J]. Nature Genetics, 2020, 52(10): 1024–1035.
[63] NATIVIO R, DONAHUE G, BERSON A, et al. Dysregulation of the epigenetic landscape of normal aging in Alzheimer’s disease[J]. Nature Neuroscience, 2018, 21(4): 497–505.
[64] LIU X, YU X, ZACK D J, et al. TiGER: A database for tissue-specific gene expression and regulation[J]. BMC Bioinformatics, 2008, 9(1): 271.
[65] YU X, LIN J, MASUDA T, et al. Genome-wide prediction and characterization of interactions between transcription factors in Saccharomyces cerevisiae[J]. Nucleic Acids Research, 2006, 34(3): 917–927.
[66] YU X, LIN J, ZACK D J, et al. Identification of tissue-specific cis-regulatory modules based on interactions between transcription factors[J]. BMC Bioinformatics, 2007, 8(1): 437.
[67] YU X, LIN J, ZACK D J, et al. Computational analysis of tissue-specific combinatorial gene regulation: predicting interaction between transcription factors in human tissues[J]. Nucleic Acids Research, 2006, 34(17): 4925–4936.
[68] BENSON D A, CAVANAUGH M, CLARK K, et al. GenBank[J]. Nucleic Acids Research, 2013, 41(Database issue): D36-42.
[69] KANG J, TANG Q, HE J, et al. RNAInter v4.0: RNA interactome repository with redefined confidence scoring system and improved accessibility[J]. Nucleic Acids Research, 2022, 50(D1): D326–D332.
[70] SZKLARCZYK D, KIRSCH R, KOUTROULI M, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest[J]. Nucleic Acids Research, 2023, 51(D1): D638–D646.
[71] ASHBURNER M, BALL C A, BLAKE J A, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium[J]. Nature Genetics, 2000, 25(1): 25–29.
[72] GENE ONTOLOGY CONSORTIUM, ALEKSANDER S A, BALHOFF J, et al. The Gene Ontology knowledgebase in 2023[J]. Genetics, 2023, 224(1): iyad031.
[73] KNOX C, WILSON M, KLINGER C M, et al. DrugBank 6.0: the DrugBank Knowledgebase for 2024[J]. Nucleic Acids Research, 2024, 52(D1): D1265–D1275.
[74] TEAM R. R: A language and environment for statistical computing.[J]. MSOR connections, 2014.
[75] TIBSHIRANI R. Regression Shrinkage and Selection via The Lasso: A Retrospective[J]. Journal of the Royal Statistical Society Series B: Statistical Methodology, 2011, 73(3): 273–282.
[76] FRIEDMAN J, HASTIE T, TIBSHIRANI R. Regularization Paths for Generalized Linear Models via Coordinate Descent[J]. Journal of Statistical Software, 2010, 33(1): 1–22.
[77] ROBIN X, TURCK N, HAINARD A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves[J]. BMC bioinformatics, 2011, 12: 77.
[78] GINESTET C. ggplot2: Elegant Graphics for Data Analysis[J]. Journal of the Royal Statistical Society Series A: Statistics in Society, 2011, 174(1): 245–246.
[79] WU T, HU E, XU S, et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data[J]. Innovation (Cambridge (Mass.)), 2021, 2(3): 100141.
[80] HAO Y, HAO S, ANDERSEN-NISSEN E, et al. Integrated analysis of multimodal single-cell data[J]. Cell, Elsevier, 2021, 184(13): 3573-3587.e29.
[81] LIU X, ZHENG X, WANG J, et al. A long non‐coding RNA signature for diagnostic prediction of sepsis upon ICU admission[J]. Clinical and Translational Medicine, 2020, 10(3).
[82] CHENG L, NAN C, KANG L, et al. Whole blood transcriptomic investigation identifies long non-coding RNAs as regulators in sepsis[J]. Journal of Translational Medicine, 2020, 18(1): 217.
[83] LI H, ZHENG X, GAO J, et al. Whole transcriptome analysis reveals non-coding RNA’s competing endogenous gene pairs as novel form of motifs in serous ovarian cancer[J]. Computers in Biology and Medicine, 2022, 148: 105881.
[84] CHENG L, WU H, ZHENG X, et al. GPGPS: a robust prognostic gene pair signature of glioma ensembling IDH mutation and 1p/19q co-deletion[J]. Bioinformatics, 2023, 39(1): btac850.
[85] MOK S C, BONOME T, VATHIPADIEKAL V, et al. A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2[J]. Cancer Cell, 2009, 16(6): 521–532.
[86] YEUNG T-L, LEUNG C S, WONG K-K, et al. TGF-β modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment[J]. Cancer Research, 2013, 73(16): 5016–5028.
[87] KING E R, TUNG C S, TSANG Y T M, et al. The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer[J]. The American Journal of Surgical Pathology, 2011, 35(6): 904–912.
[88] ELGAAEN B V, OLSTAD O K, SANDVIK L, et al. ZNF385B and VEGFA are strongly differentially expressed in serous ovarian carcinomas and correlate with survival[J]. PloS One, 2012, 7(9): e46317.
[89] YEUNG T-L, LEUNG C S, WONG K-K, et al. ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells[J]. Oncotarget, 2017, 8(10): 16951–16963.
[90] YAMAMOTO Y, NING G, HOWITT B E, et al. In vitro and in vivo correlates of physiological and neoplastic human Fallopian tube stem cells[J]. The Journal of Pathology, 2016, 238(4): 519–530.
[91] HENDRIX N D, WU R, KUICK R, et al. Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas[J]. Cancer Research, 2006, 66(3): 1354–1362.
[92] BOWEN N J, WALKER L D, MATYUNINA L V, et al. Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells[J]. BMC medical genomics, 2009, 2: 71.
[93] KOLDE R. pheatmap: Pretty Heatmaps[J]. 2015.
[94] GRAU J, GROSSE I, KEILWAGEN J. PRROC: computing and visualizing precision-recall and receiver operating characteristic curves in R[J]. Bioinformatics (Oxford, England), 2015, 31(15): 2595–2597.
[95] YANG Y, ZHANG Y, LI S, et al. A robust and generalizable immune-related signature for sepsis diagnostics[J]. Transactions on Computational Biology and Bioinformatics, 2021: 1–1.
[96] QUINTON R J, DIDOMIZIO A, VITTORIA M A, et al. Whole-genome doubling confers unique genetic vulnerabilities on tumour cells[J]. Nature, 2021, 590(7846): 492–497.
[97] KOMURA K, INAMOTO T, TSUJINO T, et al. Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents[J]. Oncogene, 2021, 40(43): 6210–6222.
[98] SHINDO K, YU J, SUENAGA M, et al. Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma[J]. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 2017, 35(30): 3382–3390.
[99] J L, L L, PA A, et al. Identification and Validation of the Diagnostic Characteristic Genes of Ovarian Cancer by Bioinformatics and Machine Learning[J]. Frontiers in genetics, Front Genet, 2022, 13.
[100] CHEN O J, CASTELLSAGUÉ E, MOUSTAFA-KAMAL M, et al. Germline Missense Variants in CDC20 Result in Aberrant Mitotic Progression and Familial Cancer[J]. Cancer Research, 2022, 82(19): 3499–3515.
[101] VILLARROYA-BELTRI C, MALUMBRES M. Mitotic Checkpoint Imbalances in Familial Cancer[J]. Cancer Research, 2022, 82(19): 3432–3434.
[102] BELUR NAGARAJ A, KOVALENKO O, AVELAR R, et al. Mitotic Exit Dysfunction through the Deregulation of APC/C Characterizes Cisplatin-Resistant State in Epithelial Ovarian Cancer[J]. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 2018, 24(18): 4588–4601.
[103] ZOU J, LI Y, LIAO N, et al. Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis[J]. Journal of Ovarian Research, 2022, 15: 30.
[104] URZÚA U, AMPUERO S, ROBY K F, et al. Dysregulation of mitotic machinery genes precedes genome instability during spontaneous pre-malignant transformation of mouse ovarian surface epithelial cells[J]. BMC Genomics, 2016, 17(Suppl 8): 728.
[105] GOU R, ZHENG M, HU Y, et al. Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer[J]. BMC Cancer, 2022, 22: 690.
[106] ZHAO Y, HE J, LI Y, et al. NUSAP1 potentiates chemoresistance in glioblastoma through its SAP domain to stabilize ATR[J]. Signal Transduction and Targeted Therapy, 2020, 5(1): 44.
[107] YADAV D K, SHARMA A, DUBE P, et al. Identification of crucial hub genes and potential molecular mechanisms in breast cancer by integrated bioinformatics analysis and experimental validation[J]. Computers in Biology and Medicine, 2022, 149: 106036.
[108] ZHENG H, WANG M, ZHANG S, et al. Comprehensive pan-cancer analysis reveals NUSAP1 is a novel predictive biomarker for prognosis and immunotherapy response[J]. International Journal of Biological Sciences, 2023, 19(14): 4689–4708.
[109] SHUKLA S, PATRIC I R P, PATIL V, et al. Methylation silencing of ULK2, an autophagy gene, is essential for astrocyte transformation and tumor growth[J]. The Journal of Biological Chemistry, 2014, 289(32): 22306–22318.
[110] LIANG P, WANG B. An autophagy-independent role of ULK1/ULK2 in mechanotransduction and breast cancer cell migration[J]. Autophagy, 2024: 1–2.
[111] LIANG P, ZHANG J, WU Y, et al. An ULK1/2-PXN mechanotransduction pathway suppresses breast cancer cell migration[J]. EMBO reports, 2023, 24(11): e56850.
[112] LI F, ZHAO C, DIAO Y, et al. MEX3A promotes the malignant progression of ovarian cancer by regulating intron retention in TIMELESS[J]. Cell Death & Disease, 2022, 13(6): 553.
[113] KAMINSKY L A, ARENA R, MYERS J, et al. Updated Reference Standards for Cardiorespiratory Fitness Measured with Cardiopulmonary Exercise Testing: Data from the Fitness Registry and the Importance of Exercise National Database (FRIEND)[J]. Mayo Clinic Proceedings, 2022, 97(2): 285–293.
[114] PAAP D, TAKKEN T. Reference values for cardiopulmonary exercise testing in healthy adults: a systematic review[J]. Expert Review of Cardiovascular Therapy, 2014, 12(12): 1439–1453.
[115] ZHANG M, YANG B, REN T, et al. Dual engine-driven bionic microneedles for early intervention and prolonged treatment of Alzheimer’s disease[J]. Journal of Controlled Release: Official Journal of the Controlled Release Society, 2024, 367: 184–196.
[116] OGAWA Y, KAKUMOTO K, YOSHIDA T, et al. Elavl3 is essential for the maintenance of Purkinje neuron axons[J]. Scientific Reports, Nature Publishing Group, 2018, 8(1): 2722.
[117] MULLIGAN M R, BICKNELL L S. The molecular genetics of nELAVL in brain development and disease[J]. European Journal of Human Genetics, Nature Publishing Group, 2023, 31(11): 1209–1217.
[118] TAN M G K, LEE C, LEE J H, et al. Decreased rabphilin 3A immunoreactivity in Alzheimer’s disease is associated with Aβ burden[J]. Neurochemistry International, 2014, 64: 29–36.
[119] SHI Q, GE Y, HE W, et al. RTN1 and RTN3 protein are differentially associated with senile plaques in Alzheimer’s brains[J]. Scientific Reports, 2017, 7(1): 6145.
[120] HE W, LU Y, QAHWASH I, et al. Reticulon family members modulate BACE1 activity and amyloid-beta peptide generation[J]. Nature Medicine, 2004, 10(9): 959–965.
[121] PLANELLS-FERRER L, URRESTI J, COCCIA E, et al. Fas apoptosis inhibitory molecules: more than death-receptor antagonists in the nervous system[J]. Journal of Neurochemistry, 2016, 139(1): 11–21.
[122] KIVISÄKK P, CARLYLE B C, SWEENEY T, et al. Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer’s disease[J]. Alzheimer’s Research & Therapy, 2022, 14(1): 58.
[123] NILSSON J, ASHTON N J, BENEDET A L, et al. Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer’s disease[J]. Alzheimer’s Research & Therapy, 2022, 14(1): 78.
[124] SALONER R, PAOLILLO E W, WOJTA K J, et al. Sex-specific effects of SNAP-25 genotype on verbal memory and Alzheimer’s disease biomarkers in clinically normal older adults[J]. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 2023, 19(8): 3448–3457.
[125] WOOD H. SNAP25—an early biomarker in AD and CJD[J]. Nature Reviews. Neurology, 2022, 18(10): 575.
[126] HALBGEBAUER S, STEINACKER P, HENGGE S, et al. CSF levels of SNAP-25 are increased early in Creutzfeldt-Jakob and Alzheimer’s disease[J]. Journal of Neurology, Neurosurgery, and Psychiatry, 2022: jnnp-2021-328646.
修改评论